This work is licensed under a Creative Commons Attribution 4.0 International License.
MS2
General Information
DRACP ID DRACP03062
Peptide Name MS2
Sequence RPEIWLTQSLQRLGDEINAYYAR
Sequence Length 23
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Induce apoptosis Mcl-1 inhibitors BH3 peptides and mimetics
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Mcl-1
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification 5/6-Fluorescein amidite
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C125H194N36O37
Absent amino acids CFHKMV
Common amino acids LR
Mass 318573
Pl 6.57
Basic residues 3
Acidic residues 3
Hydrophobic residues 8
Net charge 0
Boman Index -5958
Hydrophobicity -76.09
Aliphatic Index 93.48
Half Life
Mammalian: 1 hour
Yeast: 2 min
E.coli: 2 min
Extinction Coefficient cystines 8480
Absorbance 280nm 385.45
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25052212
Title Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
Year 2014
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.